SNU Cell Lines for High-Throughput Screening Platforms

At Cytion, we offer an extensive collection of Seoul National University (SNU) cell lines specifically optimized for high-throughput screening applications. These well-characterized cell models derived from various cancer types have become invaluable tools for drug discovery, toxicology studies, and personalized medicine approaches. SNU cell lines consistently demonstrate robust performance in automated screening platforms, providing researchers with reliable and reproducible results for identifying novel therapeutic compounds and understanding disease mechanisms.

Key Takeaways:

Diverse Cancer Origins: Enabling Targeted Screening Across Multiple Cancer Types

SNU cell lines represent a comprehensive panel derived from various cancer types, including gastric, colorectal, hepatocellular, and lung carcinomas. This diversity allows researchers to conduct parallel screening campaigns across multiple cancer models simultaneously, identifying compounds with broad-spectrum activity or those specific to certain cancer subtypes. For instance, the NCI-N87 Cells from gastric cancer origin offer distinct response patterns compared to liver-derived HepG2 Cells, enabling researchers to distinguish tissue-specific drug efficacy. By leveraging these varied models in high-throughput screening platforms, research teams can efficiently narrow down compound libraries to those with the most promising therapeutic potential for specific cancer indications.

Thoroughly Authenticated: Ensuring Experimental Reliability and Reproducibility

Each SNU cell line in our collection undergoes rigorous authentication protocols, including short tandem repeat (STR) profiling, mycoplasma testing, and genomic characterization. This comprehensive quality control process guarantees that researchers are working with genuine, contaminant-free cellular models that faithfully represent their source tissues. Our Cell line authentication - Human service validates the identity of these lines before distribution, while regular Mycoplasma testing confirms the absence of this common contaminant that can significantly alter experimental outcomes. By implementing these stringent authentication measures, Cytion ensures that high-throughput screening campaigns conducted with our SNU cell lines yield consistent, reliable results that can be confidently translated across different research environments.

Optimized for Automation: Compatible with Various High-Throughput Screening Platforms

SNU cell lines have been specifically optimized for seamless integration with automated high-throughput screening systems, addressing the technical challenges often encountered in large-scale cellular assays. These cell models demonstrate excellent adherence properties in multi-well plate formats, consistent growth patterns in reduced-serum conditions, and remarkable tolerance to DMSO—the primary vehicle for compound libraries. Their robust performance extends across diverse readout technologies, including luminescence, fluorescence, and high-content imaging platforms. When paired with our specialized Cell culture media formulations, SNU lines maintain viability during extended automated handling procedures, minimizing edge effects and ensuring uniform cellular responses across entire screening plates. This optimization significantly reduces the technical variability that can undermine screening campaigns, allowing researchers to focus on identifying genuine biological responses rather than addressing technical artifacts.